Dopamine depletion of the prefrontal cortex induces dendritic spine loss: Reversal by atypical antipsychotic drug treatment

Neuropsychopharmacology

Volumn 33, Issue 6, 2008, Pages 1276-1286

  Wang, Hui Dong ^a   Deutch, Ariel Y ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendrite; Haloperidol; Motor cortex; Olanzapine; Pyramidal cell; Schizophrenia

Indexed keywords

DOPAMINE; HALOPERIDOL; OLANZAPINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL SIZE; CONTROLLED STUDY; DENDRITIC SPINE; DOPAMINERGIC ACTIVITY; DRUG BLOOD LEVEL; LIMBIC CORTEX; MALE; NERVE CELL LESION; NONHUMAN; POSTOPERATIVE PERIOD; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SCHIZOPHRENIA; VENTRAL TEGMENTUM;

ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DENDRITIC SPINES; DOPAMINE; HALOPERIDOL; MALE; NEURONS; OXIDOPAMINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 42049111635     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301521     Document Type: Article

References (94)

1. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR et al (1999). Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156: 1580-1589.
2. Antonova E, Sharma T, Morris R, Kumari V (2004). The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 70: 117-145.
3. Arnsten AF (2004). Adrenergic targets for the treatment of cognitive deficits in schizophrenia. Psychopharmacology (Berl) 174: 25-31.
4. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18: 63-101.
5. Ballesteros-Yanez I, Ambrosio E, Benavides-Piccione R, Perez J, Torres I, Miguens M et al (2007). The effects of morphine self-administration on cortical pyramidal cell structure in addiction-prone lewis rats. Cereb Cortex 17: 238-249.
6. Bao S, Chan VT, Merzenich MM (2001). Cortical remodelling induced by activity of ventral tegmental dopamine neurons. Nature 412: 79-83.
7. Benes FM, Paskevich PA, Davidson J, Domesick VB (1985). The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 329: 265-273.
8. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B et al (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159: 1018-1028.
9. Black JE, Kodish IM, Grossman AW, Klintsova AY, Orlovskaya D, Vostrikov V et al (2004). Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry 161: 742-744.
10. Blanpied TA, Ehlers MD (2004). Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biol Psychiatry 55: 1121-1127.
11. Broadbelt K, Byne W, Jones LB (2002). Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 58: 75-81.
12. Brown SM, Henning S, Wellman CL (2005). Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb Cortex 15: 1714-1722.
13. Bymaster FP, Rasmussen K, Calligaro DO, Nelson DL, DeLapp NW, Wong DT et al (1997). In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J Clin Psychiatry 58(Suppl 10): 28-36.
14. Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA et al (2002). Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 59: 1002-1010.
15. Carlisle HJ, Kennedy MB (2005). Spine architecture and synaptic plasticity. Trends Neurosci 28: 182-187.
16. Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES et al (2001). Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85: 659-670.
17. Cerqueira JJ, Taipa R, Uylings HB, Almeida OF, Sousa N (2006). Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb Cortex (doi:10.1093/cercor/bhii08).
18. Crick F (1982). Do dendritic spines twitch? Trends Neurosci 5: 44-46.
19. Dalley JW, Cardinal RN, Robbins TW (2004). Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28: 771-784.
20. Davis KL, Kahn RS, Ko G, Davidson M (1991). Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148: 1474-1486.
21. Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen K (2001). Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 50: 510-520.
22. Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF et al (2006). Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9: 251-259.
23. Deutch AY (1992). The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl 36: 61-89.
24. Deutch AY, Cameron DS (1992). Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46: 49-56.
25. Deutch AY, Clark WA, Roth RH (1990). Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 521: 311-315.
26. Deutch AY, Tam SY, Roth RH (1985). Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res 333: 143-146.
27. Devoto P, Flore G, Vacca G, Pira L, Arca A, Casu MA et al (2003). Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology (Berl) 167: 79-84.
28. Duan H, Wearne SL, Rocher AB, Macedo A, Morrison JH, Hof PR (2003). Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb Cortex 13: 950-961.
29. Fiala JC, Spacek J, Harris KM (2002). Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Brain Res Rev 39: 29-54.
30. Freund TF, Powell JF, Smith AD (1984). Tyrosine hydroxylase- immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13: 1189-1215.
31. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM et al (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 65: 446-453.
32. Gibbs SE, D'Esposito M (2005). A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory. Psychopharmacology (Berl) 180: 644-653.
33. Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57: 65-73.
34. Goldman-Rakic PS (1996). Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 93: 13473-13480.
35. Goldman-Rakic PS (1999). The 'psychic' neuron of the cerebral cortex. Ann NY Acad Sci 868: 13-26.
36. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV (2004). Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 174: 3-16.
37. Goldman-Rakic PS, Selemon LD (1997). Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23: 437-458.
38. Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS et al (2006). Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res 86: 234-243.
39. Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE et al (2000). Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry 57: 761-768.
40. Hajszan T, Leranth C, Roth RH (2006). Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex. Biol Psychiatry 60: 639-644.
41. Halim ND, Weickert CS, McClintock BW, Hyde TM, Weinberger DR, Kleinman JE et al (2003). Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 8: 797-810.
42. Hao J, Rapp PR, Leffler AE, Leffler SR, Janssen WG, Lou W et al (2006). Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci 26: 2571-2578.
43. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Part 4): 593-624.
44. Hill JJ, Hashimoto T, Lewis DA (2006). Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiat 11: 557-566.
45. Hof PR, Haroutunian V, Friedrich Jr VL, Byne W, Buitron C, Perl DP et al (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53: 1075-1085.
46. Ingham CA, Hood SH, Arbuthnott GW (1989). Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 503: 334-338.
47. Izquierdo A, Wellman CL, Holmes A (2006). Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci 26: 5733-5738.
48. Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HB (1988). Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 269: 58-72.
49. Kalus P, Muller TJ, Zuschratter W, Senitz D (2000). The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 11: 3621-3625.
50. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM et al (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 64: 633-647.
51. Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM et al (2004). Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry 161: 985-995.
52. Knable MB, Weinberger DR (1997). Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol 11: 123-131.
53. Kolb B, Gorny G, Li Y, Samaha AN, Robinson TE (2003). Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci USA 100: 10523-10528.
54. Kolluri N, Sun Z, Sampson AR, Lewis DA (2005). Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 162: 1200-1202.
55. Krettek JE, Price JL (1977). The cortical projections of the mediodorsal nucleus and adjacent thalamic nuclei in the rat. J Comp Neurol 171: 157-191.
56. Lewis DA, Lieberman JA (2000). Catching up on schizophrenia: natural history and neurobiology. Neuron 28: 325-334.
57. Li XM, Perry KW, Wong DT, Bymaster FP (1998). Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology (Berl) 136: 153-161.
58. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al (2005a). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223.
59. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS et al (2005b). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62: 361-370.
60. Meltzer HY, Park S, Kessler R (1999). Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc Natl Acad Sci USA 96: 13591-13593.
61. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R et al (2005). Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8: 594-596.
62. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001). Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24: 479-486.
63. Murmu MS, Salomon S, Biala Y, Weinstock M, Braun K, Bock J (2006). Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur J Neurosci 24: 1477-1487.
64. Park S, Holzman PS (1992). Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49: 975-982.
65. Perez-Costas E, Guidetti P, Leeley JJ, Melendez-Ferro M, Roberts RC (2005). Neuroleptic and animals models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. Soc Neurosci (Abstr 914.18).
66. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA (2003). Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations. Biol Psychiatry 54: 111-120.
67. Radley JJ, Rocher AB, Janssen WG, Hof PR, McEwen BS, Morrison JH (2005). Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Exp Neurol 196: 199-203.
68. Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR et al (2004). Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125: 1-6.
69. Ragozzino ME, Detrick S, Kesner RP (2002). The effects of prelimbic and infralimbic lesions on working memory for visual objects in rats. Neurobiol Learn Mem 77: 29-43.
70. Rao SG, Williams GV, Goldman-Rakic PS (2000). Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20: 485-494.
71. Robinson TE, Gorny G, Mitton E, Kolb B (2001). Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39: 257-266.
72. Robinson TE, Gorny G, Savage VR, Kolb B (2002). Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46: 271-279.
73. Robinson TE, Kolb B (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497.
74. Robinson TE, Kolb B (1999). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11: 1598-1604.
75. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983). Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275: 321-328.
76. Segal M, Andersen P (2000). Dendritic spines shaped by synaptic activity. Curr Opin Neurobiol 10: 582-586.
77. Seib LM, Wellman CL (2003). Daily injections alter spine density in rat medial prefrontal cortex. Neurosci Lett 337: 29-32.
78. Selemon LD, Goldman-Rakic PS (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45: 17-25.
79. Selemon LD, Lidow MS, Goldman-Rakic PS (1999). Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry 46: 161-172.
80. Sesack SR, Carr DB, Omelchenko N, Pinto A (2003). Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann NY Acad Sci 1003: 36-52.
81. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18: 2697-2708.
82. Sherren N, Pappas BA (2005). Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood. Neuroscience 136: 445-456.
83. Solis O, Limón DI, Flores-Hernández J, Flores G (2007). Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 61: 450-458.
84. Stanwood GD, Parlaman JP, Levitt P (2005). Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice. J Comp Neurol 487: 270-282.
85. Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW et al (2005). Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132: 741-754.
86. 7 nicotinic acetylcholine receptors. Neurosci 136: 519-529.
87. Thune JJ, Uylings HB, Pakkenberg B (2001). No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J Psychiatr Res 35: 15-21.
88. Uylings HB, Groenewegen HJ, Kolb B (2003). Do rats have a prefrontal cortex? Behav Brain Res 146: 3-17.
89. Van Eden CG, Hoorneman EM, Buijs RM, Matthijssen MA, Geffard M, Uylings HB (1987). Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neuroscience 22: 849-862.
90. Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP et al (2002). Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 159: 255-262.
91. 2 receptor knockout mice. Soc Neurosci Abstr 555: 12.
92. Weinberger DR, Berman KF, Illowsky BP (1988). Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45: 609-615.
93. Youngren KD, Moghaddam B, Bunney BS, Roth RH (1994). Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment. Neurosci Lett 165: 41-44.
94. Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A et al (2005). Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64: 545-547.